title: Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice.
abstract: CL 316,243, a β3-adrenergic agonist, was developed as an antiobesity and diabetes drug and causes rapid decreases in blood glucose levels in mice. The mechanisms mediating this effect have not been fully elucidated; thus, the purpose of the current study was to examine the role of fatty acids and interleukin-6, reputed mediators of insulin secretion, in this process. To address this question, we used physiological and pharmacological approaches in combination with knockout mouse models. CL 316,243 treatment in male C57BL6 mice increased plasma fatty acids, glycerol, interleukin-6, and insulin and reduced blood glucose concentrations 2 h following injections. The ability of CL 316,243 to increase insulin and fatty acids and reduce glucose was preserved in interleukin-6-deficient mice. CL 316,243-induced drops in blood glucose occurred in parallel with increases in circulating fatty acids but prior to increases in plasma interleukin-6. CL 316,243-mediated increases in plasma insulin levels and reductions in blood glucose were attenuated when mice were pretreated with the lipase inhibitor nicotinic acid or in whole body adipose tissue triglyceride lipase knockout mice. Collectively, our findings demonstrate an important role for fatty acids in mediating the effects of CL 316,243 in mice. Not only do our results provide new insight into the mechanisms of action of CL 316,243, but they also hint at an unappreciated aspect of adipose tissue -pancreas cross-talk.
authors.affiliation: Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Rebecca E K
authors.initials: RE
authors.lastname: MacPherson
authors.affiliation: Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Laura
authors.initials: L
authors.lastname: Castellani
authors.affiliation: Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Marie-Soleil
authors.initials: MS
authors.lastname: Beaudoin
authors.affiliation: Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada dcwright@uoguelph.ca.
authors.forename: David C
authors.initials: DC
authors.lastname: Wright
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects*; D004149:Dioxoles / Q000494:pharmacology*; D005227:Fatty Acids / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005990:Glycerol / Q000097:blood*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007328:Insulin / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood* / Q000235:genetics; D008049:Lipase / Q000037:antagonists & inhibitors / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009525:Niacin / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D001786:Blood Glucose; D004149:Dioxoles; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007328:Insulin; D015850:Interleukin-6; D012333:RNA, Messenger; C577686:interleukin-6, mouse; C076126:disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate; D009525:Niacin; D008049:Lipase; D005990:Glycerol
references.citation: J Clin Endocrinol Metab. 2011 Oct;96(10):3048-55
references.pmid: 21816780
references.citation: Diabetes. 2008 Nov;57(11):2999-3006
references.pmid: 18678612
references.citation: Biochim Biophys Acta. 2010 Sep;1801(9):1048-55
references.pmid: 20435159
references.citation: Eur J Pharmacol. 2008 Apr 14;584(1):202-6
references.pmid: 18304529
references.citation: PLoS One. 2012;7(7):e41719
references.pmid: 22844518
references.citation: Diabetes. 1967 Nov;16(11):765-76
references.pmid: 6072699
references.citation: Nat Med. 2011 Oct 30;17(11):1481-9
references.pmid: 22037645
references.citation: Metabolism. 2003 Oct;52(10):1367-71
references.pmid: 14564691
references.citation: J Biol Chem. 2013 Jan 25;288(4):2882-92
references.pmid: 23235150
references.citation: J Mol Endocrinol. 2004 Oct;33(2):533-44
references.pmid: 15525607
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: PLoS One. 2012;7(10):e45874
references.pmid: 23056223
references.citation: Neurochem Int. 2005 Jan;46(2):179-87
references.pmid: 15627518
references.citation: Nature. 2003 Mar 13;422(6928):173-6
references.pmid: 12629551
references.citation: Diabetes. 2007 Apr;56(4):1087-94
references.pmid: 17395749
references.citation: Biochem J. 1990 Nov 15;272(1):243-5
references.pmid: 2264829
references.citation: Am J Physiol Regul Integr Comp Physiol. 2014 Jun 1;306(11):R861-7
references.pmid: 24694381
references.citation: Metabolism. 2011 Jan;60(1):134-44
references.pmid: 20303128
references.citation: Biochem Biophys Res Commun. 2003 Mar 28;303(1):364-9
references.pmid: 12646212
references.citation: Endocrinology. 1990 Feb;126(2):1288-94
references.pmid: 2404746
references.citation: J Biol Chem. 1997 Jul 11;272(28):17686-93
references.pmid: 9211919
references.citation: J Appl Physiol (1985). 2004 Aug;97(2):689-96
references.pmid: 15075299
references.citation: Metabolism. 2011 Jan;60(1):92-8
references.pmid: 20102773
references.citation: Diabetes. 1998 Oct;47(10):1555-61
references.pmid: 9753292
references.citation: Mol Cell Endocrinol. 2010 Aug 30;325(1-2):18-25
references.pmid: 20416356
references.citation: J Appl Physiol (1985). 2014 May 15;116(10):1272-80
references.pmid: 24674860
references.citation: Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E120-7
references.pmid: 14749208
references.citation: Science. 2006 May 5;312(5774):734-7
references.pmid: 16675698
references.citation: J Med Chem. 1992 Aug 7;35(16):3081-4
references.pmid: 1354264
references.citation: J Biol Chem. 2006 Dec 29;281(52):40236-41
references.pmid: 17074755
references.citation: EMBO J. 1991 Dec;10(12):3721-7
references.pmid: 1718744
references.citation: J Clin Invest. 1996 Jun 15;97(12):2728-35
references.pmid: 8675683
references.citation: Obesity (Silver Spring). 2014 Mar;22(3):730-8
references.pmid: 23963743
references.citation: J Clin Invest. 1969 Oct;48(10):1934-43
references.pmid: 5822597
references.citation: Endocr J. 1997 Feb;44(1):181-5
references.pmid: 9152632
references.citation: J Biol Chem. 2009 Jun 19;284(25):16848-16859
references.pmid: 19389712